Overall Status

Completed (2)

Recruiting (1)

Phase

phase 2 (2)

Sponsor

Columbia University (2)

University of California, San Francisco (1)

Collaborator

National Institute of Neurological Disorders and Stroke (NINDS) (2)

Alzheimer's Drug Discovery Foundation (1)

National Center for Advancing Translational Science (NCATS) (1)

Tau Consortium (1)

The Bluefield Project to Cure Frontotemporal Dementia (1)

Intervention

18f-av-1451 (1)

lithium carbonate (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

frontotemporal dementia (ftd)

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Frontotemporal Dementia (FTD) Trial in New York (Lithium Carbonate, Placebo)

Recruiting

Frontotemporal Dementia (FTD)

Lithium Carbonate
Placebo

New York, New York

Columbia University Medical Center

Oct 7, 2021

Frontotemporal Lobar Degeneration (ARTFL)

Completed

FTLD
+11 more

Birmingham, Alabama
+16 more

May 18, 2021

Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD), Tauopathies Trial in New York (18F-AV-1451)

Completed

Has Results

Frontotemporal Lobar Degeneration (FTLD)
+2 more

18F-AV-1451

New York, New York

Morton A. Kreitchman PET Center

Nov 18, 2019